Lynn Kirkpatrick - Ensysce Biosciences CEO Director
| ENSCWDelisted Stock | USD 0.01 0.0008 8.16% |
Insider
Lynn Kirkpatrick is CEO Director of Ensysce Biosciences
| Age | 66 |
| Phone | 858-263-4196 |
| Web | http://ensysce.com |
Similar Executives
| Found 4 records | INSIDER Age | ||
| Jeffrey Millard | Ensysce Biosciences | 48 | |
| Linda Pestano | Ensysce Biosciences | 55 | |
| MSE MBA | Ensysce Biosciences | 52 | |
| Geoffrey Birkett | Ensysce Biosciences | 61 | |
Ensysce Biosciences Leadership Team
Elected by the shareholders, the Ensysce Biosciences' board of directors comprises two types of representatives: Ensysce Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ensysce. The board's role is to monitor Ensysce Biosciences' management team and ensure that shareholders' interests are well served. Ensysce Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ensysce Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Geoff Birkett, Chief Officer | ||
| MSE MBA, Chief Officer | ||
| Lynn Kirkpatrick, CEO Director | ||
| Jeffrey Millard, Chief Officer | ||
| William Schmidt, Chief Officer | ||
| David Humphrey, Chief Officer |
Ensysce Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ensysce Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| EBITDA | (27.79 M) | ||||
| Net Income | (29.15 M) | ||||
| Total Debt | 4.44 M | ||||
| Cash Flow From Operations | (8.24 M) | ||||
| Total Asset | 16.42 M | ||||
| Z Score | -3.3 | ||||
| Net Asset | 16.42 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |